Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Aksamit

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The European Respiratory Journal|January 27, 2018
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasisTimothy Aksamit, Anthony De Soyza, Tiemo-Joerg Bandel, et al.
Chest|August 28, 2020
Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians' Interpretation of a US Food and Drug Administration WorkshopPatrick A Flume, David E Griffith, James D Chalmers, et al.
Bulletin of the World Health Organization|January 30, 2025
Digitalization of health care in low- and middle-income countriesDominique J Monlezun, Lillian Omutoko, Patience Oduor, et al.
Archivos De Bronconeumologia|December 20, 2025
The Worldwide Puzzle of Bronchiectasis Etiology in AdultsMiguel Angel Martinez-Garcia, Timothy Aksamit, Takanori Asakura, et al.
Annals of the American Thoracic Society|September 15, 2016
Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop ReportEmily Henkle, Timothy Aksamit, Alan Barker, et al.
American Journal of Respiratory and Critical Care Medicine|February 6, 2007
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseasesDavid E Griffith, Timothy Aksamit, Barbara A Brown-Elliott, et al.
Nutrients|January 10, 2026
The Responsible Health AI Readiness and Maturity Index (RHAMI): Applications for a Global Narrative Review of Leading AI Use Cases in Public Health NutritionDominique J Monlezun, Gary Marshall, Lillian Omutoko, et al.
ERJ Open Research|April 3, 2023
Management of nontuberculous mycobacteria in lung transplant cases: an international Delphi studyHuda Asif, Franck F Rahaghi, Akihiro Ohsumi, et al.
The European Respiratory Journal|March 24, 2018
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statementJakko van Ingen, Timothy Aksamit, Claire Andrejak, et al.
The European Respiratory Journal|June 10, 2017
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical researchAdam T Hill, Charles S Haworth, Stefano Aliberti, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The European Respiratory Journal|January 27, 2018
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasisTimothy Aksamit, Anthony De Soyza, Tiemo-Joerg Bandel, et al.
Chest|August 28, 2020
Development of Drugs for Nontuberculous Mycobacterial Disease: Clinicians' Interpretation of a US Food and Drug Administration WorkshopPatrick A Flume, David E Griffith, James D Chalmers, et al.
Bulletin of the World Health Organization|January 30, 2025
Digitalization of health care in low- and middle-income countriesDominique J Monlezun, Lillian Omutoko, Patience Oduor, et al.
Archivos De Bronconeumologia|December 20, 2025
The Worldwide Puzzle of Bronchiectasis Etiology in AdultsMiguel Angel Martinez-Garcia, Timothy Aksamit, Takanori Asakura, et al.
Annals of the American Thoracic Society|September 15, 2016
Patient-Centered Research Priorities for Pulmonary Nontuberculous Mycobacteria (NTM) Infection. An NTM Research Consortium Workshop ReportEmily Henkle, Timothy Aksamit, Alan Barker, et al.
American Journal of Respiratory and Critical Care Medicine|February 6, 2007
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseasesDavid E Griffith, Timothy Aksamit, Barbara A Brown-Elliott, et al.
Nutrients|January 10, 2026
The Responsible Health AI Readiness and Maturity Index (RHAMI): Applications for a Global Narrative Review of Leading AI Use Cases in Public Health NutritionDominique J Monlezun, Gary Marshall, Lillian Omutoko, et al.
ERJ Open Research|April 3, 2023
Management of nontuberculous mycobacteria in lung transplant cases: an international Delphi studyHuda Asif, Franck F Rahaghi, Akihiro Ohsumi, et al.
The European Respiratory Journal|March 24, 2018
Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statementJakko van Ingen, Timothy Aksamit, Claire Andrejak, et al.
The European Respiratory Journal|June 10, 2017
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical researchAdam T Hill, Charles S Haworth, Stefano Aliberti, et al.
Pageof 3